SEC Form 4 · accession 0001354488-17-000076
Pharma-Bio Serv, Inc. · PBSV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irving L Wiesen
Director
Period of report
Jan 10, 2017
Accepted (ET)
Jan 12, 2017 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001304161
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $0.91 | Jan 10, 2017 | A | 20,000 | A | — | Jan 10, 2022 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option vests in two equal installments on July 10, 2017 and July 10, 2018.